MDR Obliterates Earnings
It's hard not to get too excited about MDR. I've been gung ho about this stock for a long time, talking about it and even admittedly whining about it when it wouldn't rise.
Well, it has hit with a vengeance.
* Revenue up 100%+ and beat expectations by 9%
* Earnings up 182% and beat expectations by 84%
It's all about strong and growing margins. They have pricing control: backlog grew from $5.9B to $7.9B. That's 18 months of sales at current levels.
Where does it go from here? until 2 weeks ago, it had an 18 P/E and a 16 forward P/E. (yeah, an 18 P/E with 200% growth). It will be $66 to keep to the 18 P/E. But the forward EPS will probably be revised up to $4.50. That's $70.
Stock split soon.
Well, it has hit with a vengeance.
* Revenue up 100%+ and beat expectations by 9%
* Earnings up 182% and beat expectations by 84%
It's all about strong and growing margins. They have pricing control: backlog grew from $5.9B to $7.9B. That's 18 months of sales at current levels.
Where does it go from here? until 2 weeks ago, it had an 18 P/E and a 16 forward P/E. (yeah, an 18 P/E with 200% growth). It will be $66 to keep to the 18 P/E. But the forward EPS will probably be revised up to $4.50. That's $70.
Stock split soon.
posted by Andrew at
6:20 PM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home